Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates:: Correlation with results of NCCLS M27-A2 multicenter study

被引：11

作者：

Cantón, E

Pemán, J

Gobernado, M

Alvarez, E

Baquero, F

Cisterna, R

Gil, J

Martín-Mazuelos, E

Rubio, C

Sánchez-Sousa, A

Serrano, C

机构：

[1] Hosp Univ Fe, Ctr Invest, Univ Microbiol Expt, Valencia 46009, Spain

[2] Hosp Univ Fe, Microbiol Serv, Valencia 46009, Spain

[3] Hosp Univ Ramon & Cajal, Madrid, Spain

[4] Hosp Univ Basurto, Bilbao, Spain

[5] Univ Lozano Blesa, Hosp Clin, Zaragoza, Spain

[6] Hosp Univ Valme, Seville, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 04期

关键词：

D O I：

10.1128/AAC.49.4.1604-1607.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The ability of Sensititre YeastOne to discriminate isolates with reduced caspofungin susceptibility was determined against 36 Candida spp. (6 with a known FKS1 mutation). Results were compared with those of M27-A2. The MIC endpoint was 100% growth inhibition. Overall agreement (+/- 2 log(2)) was 87.16%. Sensititre YeastOne detected strains with reduced caspofungin susceptibility.

引用

收藏

页码：1604 / 1607

页数：4

相关论文

共 22 条

[1] Quality control limits for broth microdilution susceptibility tests of ten antifungal agents [J].

Barry, AL ;

Pfaller, MA ;

Brown, SD ;

Espinel-Ingroff, A ;

Ghannoum, MA ;

Knapp, C ;

Rennie, RP ;

Rex, JH ;

Rinaldi, MG .

JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3457-3459

[2] Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus [J].

Bartizal, C ;

Odds, FC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2100-2107

[3]

Cantón E, 1999, J CLIN MICROBIOL, V37, P2197

[4] Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors [J].

Douglas, CM ;

DIppolito, JA ;

Shei, GJ ;

Meinz, M ;

Onishi, J ;

Marrinan, JA ;

Li, W ;

Abruzzo, GK ;

Flattery, A ;

Bartizal, K ;

Mitchell, A ;

Kurtz, MB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2471-2479

[5] Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp. [J].

Espinel-Ingroff, A ;

Pfaller, M ;

Messer, SA ;

Knapp, CC ;

Holliday, N ;

Killian, SB .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (02) :718-721

[6] Multicenter comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms [J].

Espinel-Ingroff, A ;

Pfaller, M ;

Messer, SA ;

Knapp, CC ;

Killian, S ;

Norris, HA ;

Ghannoum, MA .

JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (03) :591-595

[7] Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts [J].

Espinel-Ingroff, A .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :2950-2956

[8] Caspofungin: the first in a new class of antifungal agents [J].

Kartsonis, NA ;

Nielsen, J ;

Douglas, CM .

DRUG RESISTANCE UPDATES, 2003, 6 (04) :197-218

[9] Characterization of echinocardin-resistant mutants of Candida albicans: Genetic, biochemical, and virulence studies [J].

Kurtz, MB ;

Abruzzo, G ;

Bartizal, K ;

Marrinan, JA ;

Li, W ;

Milligan, J ;

Nollstadt, K ;

Douglas, CM .

INFECTION AND IMMUNITY, 1996, 64 (08) :3244-3251

[10] Adding 2% glucose to culture media does not influence the activity of caspofungin against Candida species [J].

Laverdiere, M ;

Restieri, C ;

Habel, F .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) :183-U17